Press releases | Gradientech

2024-10-09

Gradientech welcomes investment from commercial partner

Gradientech AB (publ) ("Gradientech" or the "Company") announced on October 8 the exclusive partnership with Hardy Diagnostics for the…

2024-10-08

Gradientech in exclusive partnership with Hardy Diagnostics for the US and Canadian markets

The diagnostics company Gradientech today announces the exclusive partnership with Hardy Diagnostics for the commercialisation of its QuickMIC® system…

2024-10-01

QuickMIC® proves superior speed and performance in multicenter study

The diagnostics company Gradientech announces a new scientific publication of the QuickMIC® system, the today fastest diagnostic system on…

2024-09-06

Gradientech starts US 510(k) study for QuickMIC® at clinical sites

The diagnostics company Gradientech today announces to have started the 510(k) clinical study for the QuickMIC® system for ultra-rapid…

2024-09-04

New QuickMIC® publication in ASM journal

The diagnostics company Gradientech announces a new scientific publication of the QuickMIC® system by Dr. Balmis University General Hospital…

2024-08-23

Gradientech receives patent rights in Japan

The diagnostics company Gradientech reports having received a Notice of Allowance in Japan for its QuickMIC® cassette, the single-use…

2024-08-22

Gradientech: Interim report January–June 2024

Gradientech AB (publ) interim report for Q2 2024 is now available on the company's website www.gradientech.se.

2024-08-12

Nathan A Ledeboer joins the Scientific Advisory Board at Gradientech

The diagnostics company Gradientech today announces that Dr Nathan A. Ledeboer, specialist within the Froedtert & Medical College of…

2024-07-08

Gradientech announces outcome of directed issue of shares

Gradientech AB (publ) ("Gradientech" or the "Company") announces that the Company's directed issue of shares to a limited number…

2024-07-04

Gradientech and Momentum Bioscience in continued collaboration

The diagnostics company Gradientech today announces the continued collaboration with Oxford-based Momentum Bioscience Ltd in the ground-breaking project to…

2024-06-11

Promising QuickMIC® data from two US study sites will be presented at ASM Microbe 2024

The diagnostics company Gradientech today announces that data from the successfully completed US pre-clinical evaluation of QuickMIC® will be…

2024-05-24

QuickMIC® installation for clinical routine use in Central Eastern Europe

The diagnostics company Gradientech today announces that Biomedica Medizinprodukte GmbH, its appointed distributor for Austria, Switzerland, and Central Eastern…

2024-05-17

Gradientech: Interim report January–March 2024

Gradientech AB (publ) interim report for Q1 2024 is now available on the company's website www.gradientech.se.

2024-05-07

Gradientech receives patent rights in China

The diagnostics company Gradientech reports having received a Notification to Grant Patent Rights in China for its QuickMIC® cassette,…

2024-05-02

Gradientech releases new ebook

The diagnostics company Gradientech today announces the release of its new ebook “Stop treating all patients equally” – a…

2024-04-25

Gradientech at ESCMID Global 2024

The diagnostics company Gradientech announces the presentation of new performance data from clinical, real-world evaluations with its QuickMIC[®] system…

2024-04-18

Gradientech strengthens its commercial management team

The diagnostics company Gradientech today announces that AnnaLotta Schiller Vestergren has been appointed as the company’s Chief Commercial Officer…

2024-04-12

Gradientech publishes Annual Report for 2023

Gradientech AB's Annual Report for 2023 has been published and is now available on the company's website.

2024-03-28

Gradientech unveils European clinical study data

The diagnostics company Gradientech today announces the publication of data from the large multicenter clinical study of the QuickMIC®…

2024-03-07

Gradientech´s distributor Triolab starts its first commercial evaluation with QuickMIC® in Sweden

The diagnostics company Gradientech today announces that its assigned distributor for Sweden, Triolab AB, will start its first commercial…

2024-03-05

New clinical study to evaluate QuickMIC® in the diagnostic workflow of urosepsis

Uppsala, Sweden, March 5, 2024. The diagnostics company Gradientech today announces the start of a new prospective and observational…

2024-02-22

Gradientech: Year-end report 2023

Gradientech AB (publ) year-end report for 2023 is now available on the company's website www.gradientech.se.

2024-02-02

All-time high in QuickMIC® abstracts at ECCMID 2024

The diagnostics company Gradientech today announces that six QuickMIC® abstracts will be presented at the 34th European Congress of…

2024-01-19

Gradientech completes successful pre-clinical testing in the US

The diagnostics company Gradientech today announces the successful completion of its pre-clinical testing of the QuickMIC® system in the…

2024-01-16

Gradientech receives QuickMIC® order from Iberlab in Portugal

The diagnostic company Gradientech today announces the first order from their recently assigned distributor in Portugal.

2023-12-11

Gradientech announces oversubscribed rights issue

Gradientech AB (publ) announces that the company's rights issue, for which the subscription period ended on December 6, 2023,…

2023-11-16

Gradientech: Interim report 1 January–30 September 2023

Gradientech AB (publ) interim report for Q3 2023 is now available on the company's website www.gradientech.se.

2023-10-25

Gradientech signs exclusive contract with UK distributor

The diagnostic company Gradientech today announces an exclusive distribution agreement with AB Scientific for the commercialisation of QuickMIC® in…

2023-10-18

Gradientech expands its distribution network in Europe

The diagnostic company Gradientech today announces an exclusive distribution agreement with Iberlab for the commercialisation of QuickMIC® in Portugal.

2023-10-06

QuickMIC® finalist in Applied Microbiology International Product of the Year Award

The diagnostic company Gradientech today announces that the QuickMIC® system for ultra-rapid antibiotic susceptibility testing (AST) is a finalist…

2023-09-21

Gradientech presents new QuickMIC® results at NSCMID 2023

Gradientech will present new promising data from an ongoing study of the QuickMIC® rapid AST system at the the…

2023-08-31

Gradientech files patent application regarding early prediction of resistance mechanism using machine learning

The diagnostics company Gradientech AB (publ) today announces that they have filed a patent application with the Swedish Patent…

2023-08-24

Gradientech: Interim report 1 January – 30 June 2023

Gradientech AB (publ) interim report for Q2 2023 is now available on the company's website www.gradientech.se.

2023-07-18

QuickMIC® receives Breakthrough Device Designation from the U.S. Food and Drug Administration

The diagnostics company Gradientech today announces that the U.S. Food and Drug Administration, FDA, has granted Breakthrough Device Designation…

2023-07-12

Gradientech announces outcome of issue of convertible instruments

Gradientech AB (publ) (“Gradientech” or “the Company”) announces that the Company's issue of convertible instruments with deviation from the…

2023-07-07

Gradientech presents QuickMIC® at FEMS 2023

Gradientech will display its ultra-rapid and precise diagnostic system QuickMIC® at the FEMS Congress of European Microbiologists in Hamburg,…

2023-07-06

Gradientech starts pre-clinical testing in the US

The diagnostics company Gradientech today announces the starting of pre-clinical testing in the US.

2023-06-15

Gradientech presents QuickMIC® results at ASM Microbe 2023

Gradientech announces the presentation of promising results from two collaborative studies on its ultra-rapid diagnostic system QuickMIC® at ASM…

2023-05-17

Gradientech: Interim report 1 January – 31 March 2023

Gradientech AB (publ) interim report for Q1 2023 is now available on the company's website www.gradientech.se.

2023-05-16

Gradientech announces appointment of Hilja Ibert and Nedal Safwat to Board of directors

The diagnostics company Gradientech today announces the appointment of Dr Hilja Ibert and Dr Nedal Safwat to the Gradientech…

2023-04-27

Gradientech welcomes investment from commercial partner

The diagnostics company Gradientech today announces the collaboration with a.d.a. SRL as commercial partner for the Italian clinical microbiology…

2023-04-26

New data presented at ECCMID confirms that QuickMIC® outputs accurate AST results in record time

Gradientech today announces that the recently presented abstract “A multi-center evaluation of a novel microfluidic rapid AST assay for…

2023-04-14

Gradientech presents QuickMIC® results at ECCMID

Uppsala, Sweden, 14 April 2023. Gradientech announces that it will present promising results from two collaborative studies of its…

2023-04-14

Gradientech publishes annual report for 2022

Gradientech's annual report for 2022 has today been published on the company's website.

2023-02-23

Gradientech: Year-end Report 2022

The year-end report 2022 for Gradientech AB (publ) is now available on the company's website www.gradientech.se.

2023-01-23

Gradientech announces outcome of rights issue

Gradientech AB (publ) (“Gradientech” or “the Company”) announces that the Company's rights issue (the “Rights Issue”), in which the…

2022-12-22

Gradientech carries out a rights issue of approximately SEK 50 m

The Board of Directors of Gradientech AB (publ) (“Gradientech” or “the Company”) decided on 16 December to carry out…

2022-12-22

Gradientech carries out a rights issue of approximately SEK 50 m

The Board of Directors of Gradientech AB (publ) (“Gradientech” or “the Company”) decided on 16 December to carry out…

2022-11-17

Gradientech: Interim report 1 January – 30 September 2022

Gradientech AB (publ) interim report for Q3 2022 is now available on the company's website www.gradientech.se.

2022-10-20

Gradientech’s Nomination Committee for the 2023 Annual General Meeting

The Nomination Committee for Gradientech AB prior to the 2023 Annual General Meeting has been appointed based on the…

2022-10-04

Gradientech expands with senior business development presence in the US

The diagnostics company Gradientech today announces the signing of a long-term agreement with Marc van Nuenen for heading the…

2022-09-12

Gradientech signs additional distribution agreement for Europe

The diagnostics company Gradientech today announces exclusive distribution agreements with the Triolab group for the commercialization of QuickMIC® in…

2022-08-25

Gradientech: Interim report 1 January – 30 June 2022

Gradientech AB (publ) interim report for Q2 2022 is now available on the company's website www.gradientech.se.

2022-08-15

Gradientech releases IVDR-compliant QuickMIC instrument and sample preparation kit

The diagnostics company Gradientech today announces that instrument and sample preparation kit as part of the previously CE-IVD marked…

2022-07-01

Gradientech signs distribution agreement for Europe

The diagnostics company Gradientech today announces an exclusive distribution agreement with Biomedica for the commercialization of QuickMIC® in Austria,…

2022-06-21

Invitation to QuickMIC® launch webinar

Gradientech is hosting a live webinar on the 29th of June 2022 at 14:00 (CEST). Current developments in next generation…

2022-06-21

Invitation to QuickMIC® launch webinar

Gradientech is hosting a live webinar on the 29th of June 2022 at 14:00 (CEST). Current developments in next generation…

2022-05-24

Gradientech’s diagnostic system QuickMIC® achieves CE-IVD approval

The diagnostics company Gradientech today announces CE-IVD registration of its first diagnostic product QuickMIC® and its gram-negative panel. The…

2022-05-19

Gradientech: Interim report January 1 – March 31, 2022

Gradientech AB (publ) interim report for Q1 2022 is now available on the company's website www.gradientech.se.

2022-05-17

Gradientech presents QuickMIC® clinical study results

The diagnostics company Gradientech, developing QuickMIC® for ultra-rapid antibiotic susceptibility testing, today announces decisive results from the completed clinical…

2022-04-22

Gradientech presents QuickMIC® at ECCMID 2022

Uppsala, Sweden, April 22, 2022. Gradientech will display its ultra-rapid and precise diagnostic system QuickMIC® on April 23-26 at…

2022-04-19

Gradientech publishes annual report for 2021

Gradientech's annual report for 2021 has today been published on the company's website.

2022-04-12

New leading expertise to Gradientech’s Scientific Advisory Board

The diagnostics company Gradientech announces today that Elisabet Nielsen, Senior Lecturer and Assoc. Professor in Clinical Pharmacy at Uppsala…

2022-04-01

Urban Adolfsson new CFO at Gradientech

Uppsala, 1 April 2022. The diagnostics company Gradientech announces today that Urban Adolfsson is taking up the position as…

2022-03-28

New article published on the QuickMIC® system

Uppsala, 28 March, 2022. Gradientech AB (publ) today announces a new scientific publication of its diagnostic QuickMIC® system, demonstrating…

2022-03-28

New article published on the QuickMIC® system

Uppsala, 28 March, 2022. Gradientech AB (publ) today announces a new scientific publication of its diagnostic QuickMIC® system, demonstrating…

2022-02-25

Year-end report 2021

Gradientech AB (publ) year-end report for 2021 is now available on the company's website www.gradientech.se.

2022-01-17

Gradientech starts decisive clinical study in Europe for QuickMIC®

Uppsala, 17 January, 2022. Gradientech AB (publ) announces the start of the clinical study of its diagnostic QuickMIC® system.

2022-01-03

Gradientech announces outcome of rights issue

Uppsala, 3 January, 2022. Gradientech AB (publ) (“Gradientech” or “the Company”) announces that the Company's rights issue (the “Rights…

2021-12-08

Gradientech carries out a rights issue of approximately SEK 83.4 m

Uppsala, 8 December, 2021. The Board of Directors of Gradientech AB (publ) (“Gradientech” or “the Company”) decided on November…

2021-11-19

Gradientech: Interim report January 1 – September 30, 2021

Gradientech AB (publ) interim report for Q3 2021 is now available on the company's website www.gradientech.se.

2021-09-06

Laura Chirica appointed new Board Director in Gradientech

Uppsala, 6 September 2021. The Extra General Meeting at the diagnostic company Gradientech today elected Laura Chirica new Board Director.

2021-08-20

Gradientech: Interim report January 1 – June 30, 2021

Gradientech AB (publ) interim report for Q2 2021 is now available on the company's website www.gradientech.se.

2021-06-08

Gradientech’s QuickMIC® showed rapid and reliable results in new study

Gradientech is pleased to announce positive study results obtained from clinical blood culture samples using QuickMIC, Gradientech’s ultra-rapid antibiotic…

2021-05-12

Gradientech: Interim report 1 January 1 – 31 March 2021

Gradientech AB (publ) interim report for Q1 2021 is now available in Swedish on the company's website www.gradientech.se.

2021-04-19

Gradientech publishes annual report for 2020

Gradientech's annual report for 2020 has today been published on the company's website.

2021-04-15

QuickMIC® wins additional prestigious design award

Already a winner of the RedDot Design Award2021, Gradientech has been awarded this year’s iF DESIGN AWARD for its…

2021-03-25

QuickMIC® wins Red Dot Design Award 2021

Gradientech has been awarded the Red Dot Award: Product Design 2021 for its QuickMIC diagnostic system for ultra-rapid antibiotic…

2021-03-02

Gradientech: Year-end report for 2020

Gradientech AB (publ) year-end report for 2020 is now available in Swedish on the company's website www.gradientech.se.

2021-03-01

Gradientech Announces First External QuickMIC System Installation

Gradientech AB (publ) today announced that their QuickMIC system for rapid antibiotic susceptibility testing (AST) is currently being used…

2020-12-15

Gradientech Announces Prominent International Scientific Advisory Board

Swedish diagnostics firm Gradientech is proud to announce the appointment of three internationally renowned members to the company’s scientific…

2020-11-10

Gradientech: Interim report 1 January 1 – 30 September 2020

Gradientech AB (publ) interim report for Q3 2020 is now available in Swedish on the company's website www.gradientech.se.

2020-10-14

Gradientech secures $9 million in oversubscribed investment round

Innovative Swedish diagnostics company Gradientech announces closure of an oversubscribed financing round totalling $9 million (SEK 80 million). The…

2020-08-18

Gradientech: Interim report 1 January 1 – 30 June 2020

Gradientech AB (publ) interim report for Q2 2020 is now available in Swedish on the company's website www.gradientech.se.

2020-07-28

QuickMIC Instrument Certified for Research Use

Gradientech is pleased to announce that the QuickMIC® instrument, which is part of the antibiotic susceptibility testing system in…

2020-06-12

Rapid ID+AST pilot study highlighted at ECCMID 2020

The pilot study, led by Gradientech, combined rapid ID+AST technologies – T2Bacteria (ID) and QuickMIC (AST) and compared the…

2020-05-25

Gisela Sitbon, Rolf Ehrnström and Simon Turner new board members of Gradientech

Uppsala, May 25, 2020. Gradientech is pleased to announce the appointment of three new members to the company's board…

2020-05-05

Gradientech: Interim report 1 January 1 – 31 March 2020

Gradientech AB (publ) interim report for Q1 2020 is now available in Swedish on the company's website www.gradientech.se.

2020-04-30

Gradientech closes SEK 21 million in oversubscribed rights issue

Uppsala, April 30, 2020. Gradientech has closed a rights issue among its existing shareholders for a total of USD…

2020-04-20

Gradientech publishes annual report for 2019

Gradientech AB (publ) announces today that the annual report for 2019 has been published and is available on the…

2020-03-27

Gradientech receives SEK 6.3M from BIO-X® Accelerate program

Uppsala, March 27, 2020. Gradientech has been awarded with SEK 6.3M from the highly competitive BIO-X Accelerate program, to…

2020-02-26

New publication by Gradientech and Uppsala University on rapid AST platform

Uppsala, February 26, 2020. Gradientech today announces the scientific publication of a navel multiplex fluidic chip for rapid antibiotic…

2020-01-24

Gradientech: Year-end report for 2019

Gradientech AB (publ) year-end report for 2019 is now available in Swedish on the company's website www.gradientech.se.

2019-08-29

Gradientech Granted Trademark for QuickMIC from United States Patent and Trademark Office

Uppsala, August 29, 2019. Gradientech AB today announces the trademark approval from the United States Patent and Trademark Office…

2019-08-21

Gradientech announces Notice of Allowance from United States Patent and Trademark Office

Uppsala, August 21, 2019. Gradientech AB, today announces that the company has received a Notice of Allowance from the…

2019-04-12

Gradientech previews QuickMIC™, an ultra-rapid IVD system for antibiotic susceptibility testing (AST) at ECCMID 2019

Uppsala, Sweden, April 12, 2019. Gradientech is displaying its QuickMIC™ system for the first time at ECCMID, the world’s…

2019-04-04

Gradientech closes fully subscribed USD 4.6million rights issue to progress QuickMIC™ diagnostic system for ultra-rapid AST testing

Uppsala, Sweden, April 4, 2019. Swedish biotechnology company Gradientech today announced it has closed a fully subscribed rights issue…

2019-03-20

Gradientech announces Notice of Allowance from Chinese Patent Office

Uppsala, March 20, 2079. Gradientech AB, a Swedish biotech and diagnostic company developing the next generation ultra-rapid antibiotic susceptibility…

2019-03-18

Gradientech responds to call for new diagnostic approaches to combat antimicrobial resistance at AMR Conference in Berlin

Uppsala, Sweden, March 18, 2019. Speaking at the Novel Antimicrobials and AMR Diagnostics Conference in Berlin, Gradientech, developer of…

2019-02-15

Gradientech achieves transition accreditation toISO 13485:2016

Uppsala, February 15, 2019. Gradientech AB has successfully transitioned to the latest revision of ISO13485:2016,an important regulatory requirement forCE-marking…

2018-08-30

Gradientech closes $2.2M Equity Funding Round

Uppsala Sweden, August 30, 2018. The Swedish biotech and diagnostics firm Gradientech has successfully raised 20 MSEK ($2.2M) in…